Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03639233 · ClinicalTrials.gov registry record · NA

Youth Epilepsy and Successful Self-Management Intervention

A NA study of Epilepsy, sponsored by University of Minnesota.

Completed
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT03639233 is a NA study of Epilepsy that has completed, run by University of Minnesota. The registered enrollment target is 120 participants, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03639233, a NA study of Epilepsy, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

This study is designed as a pilot test of the YESS! web-based intervention for adolescents with epilepsy. One hundred twenty participants will be given access to the intervention for a period of eight weeks. The investigators are testing the feasibility and acceptability of the the study procedures, measures and of the intervention itself. The study also evaluats the potential for impact on the users.

Conditions Studied

Interventions

  • BEHAVIORAL YESS!

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2018-10-01
Est. Completion 2019-09-01
Phase NA

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT03639233

The ClinicalTrials.gov registry entry for NCT03639233 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (87% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which YESS! is the first listed.

NCT03639233 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT03639233 about?

NCT03639233 is a clinical study titled "Youth Epilepsy and Successful Self-Management Intervention". This study is designed as a pilot test of the YESS! web-based intervention for adolescents with epilepsy. One hundred twenty participants will be given access to the intervention for a period of eight weeks. The investigators are testing the feasibility and acceptability of the the study procedures,...

What is the current status of trial NCT03639233?

This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2018-10-01. Estimated completion is 2019-09-01.

What conditions does trial NCT03639233 study?

This clinical trial studies the following conditions: Epilepsy.

What interventions are being tested in trial NCT03639233?

The interventions under investigation include: YESS! (BEHAVIORAL).

Who is sponsoring clinical trial NCT03639233?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03639233 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Epilepsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.